Clinical Study

Treatment Planning Methods in High Dose Rate Interstitial Brachytherapy of Carcinoma Cervix: A Dosimetric and Radiobiological Analysis

Table 1

Dosimetrical and radiobiological data for the ISBT planning methods.

Quality metricGr_O (mean)DP_N (mean/ )DP_O (mean/ )G_N (mean/ )G_O (mean/ )

CI0.73200.7360 (0.87)0.8561 (0.0001)0.8356 (0.0004)0.8879 (0.0001)
EI0.00090.0174 (0.0001)0.0114 (0.0035)0.0441 (0.0001)0.0406 (0.0001)
DHI0.66290.6282 (0.1647)0.6070 (0.049)0.4494 (0.0001)0.4764 (0.0001)
ODI0.13430.1284 (0.5555)0.1599 (0.0077)0.1835 (0.0002)0.1514 (0.0632)
DNR0.33700.3717 (0.1647)0.3929 (0.0049)0.5205 (0.0001)0.5535 (0.0001)
Bl2cc425.65461.72 (0.0697)473.35 (0.0078)524.37 (0.0001)533.07 (0.0001)
R2cc416.12520.62 (0.0001)504.95 (0.0001)595.32 (0.0001)620.47 (0.0001)
TCP0.99520.9951 (0.0343)0.9958 (0.5353)0.9964 (0.0641)0.9959 (0.9274)
NTCP-B0.32520.3607 (0.0001)0.7752 (0.0001)0.7115 (0.0001)0.8895 (0.0001)
NTCP-R0.31260.7216 (0.0001)0.7032 (0.0001)0.8569 (0.0001)0.8112 (0.0001)

CI: Conformity Index; EI: External Volume Index; DHI: Dose Homogeneity Index; ODI: Overdose Volume Index; DNR: Dose nonuniformity Ratio; Bl2cc: dose to 2cc bladder volume; R2cc: dose to 2cc rectal volume; NTCP-B: normal tissue complication probability of bladder; NTCP-R: normal tissue complication probability of rectum; DP_N: volume normalization; DP_O: dose point optimization; G_N: geometrical normalization; and G_O: geometrical optimization.